Yuko Motohashi1, Hiroyuki Yajima2, Akihiko Ishiyama1, Eri Takeshita1, Yoko Kobayashi2, Hirofumi Komaki1, Masayuki Sasaki1 (1.National Center of Neurology and Psychiatry, Department of Child Neurology, Tokyo, Japan, 2.National Center of Neurology and Psychiatry, Department of Rehabilitation, Tokyo, Japan)
Session information
English session
Nerve / Muscular disease
[E4] English session
Nerve / Muscular disease
Fri. May 31, 2019 3:30 PM - 4:30 PM Room 8 (Conference Room 131+132, 3F, Bldg. 1)
Chair: Yuka Ishikawa (Department of Pediatrics, Yakumo National Hospital), Yasuhiro Takeshima (Department of Pediatrics, Hyogo College of Medicine)
Laurent Servais1,2, Giovanni Baranello3, John W. Day4, Nicolas Deconinck5, Eugenio Mercuri6, Andrea Klein7, Basil Darras8, Riccardo Masson1,2, Heidemarie Kletzl9, Muna El-Khairi10, Timothy Seabrook9, Marianne Gerber9, Ksenija Gorni9, Omar Khwaja9 (1.Institute of Myology, Paris, France, 2.Reference Center for Neuromuscular Disease, Centre Hospitalier Régional de La Citadelle, Liège, Belgium, 3.Carlo Besta Neurological Research Institute Foundation, Developmental Neurology Unit, Milan, Italy, 4.Department of Neurology, Stanford University, Palo Alto, CA, USA, 5.Queen Fabiola Children’s University Hospital, Université Libre de Bruxelles, Brussels, Belgium; Neuromuscular Reference Center UZ Ghent; Ghent, Belgium, 6.Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, Rome, Italy, 7.University Children’s Hospital Basel, Basel, Switzerland; Inselspital, Bern, Switzerland, 8.Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA, 9.Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland, 10.Roche Products Ltd, Welwyn Garden City, UK)
Timothy Seabrook1, Laurent Servais2,3, Giovanni Baranello4, John W. Day5, Nicolas Deconinck6, Eugenio Mercuri7, Andrea Klein8, Basil Darras9, Riccardo Masson2,3, Heidemarie Kletzl1, Muna El-Khairi10, Marianne Gerber1, Ksenija Gorni1, Omar Khwaja1 (1.Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland, 2.Institute of Myology, Paris, France, 3.Reference Center for Neuromuscular Disease, Centre Hospitalier Régional de La Citadelle, Liège, Belgium, 4.Carlo Besta Neurological Research Institute Foundation, Developmental Neurology Unit, Milan, Italy, 5.Department of Neurology, Stanford University, Palo Alto, CA, USA, 6.Queen Fabiola Children’s University Hospital, Université Libre de Bruxelles, Brussels, Belgium; Neuromuscular Reference Center UZ Ghent; Ghent, Belgium, 7.Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, Rome, Italy, 8.University Children’s Hospital Basel, Basel, Switzerland; Inselspital, Bern, Switzerland, 9.Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA, 10.Roche Products Ltd, Welwyn Garden City, UK)
John W. Day1, Claudia Chiriboga2, Thomas O. Crawford3, Richard S. Finkel4, Kayoko Saito5, Mari Matsuo5, Tamaki Kato5, Authorship Truncated6, Douglas M. Sproule7, Jerry R. Mendell8 (1.Stanford University Medical Center, Stanford, CA, USA, 2.Columbia University Medical Center, New York, NY, USA, 3.Johns Hopkins Medicine, Baltimore, MD, USA, 4.Nemours Childrens Hospital, Orlando, FL, USA, 5.Tokyo Womens Medical University, Tokyo, Japan, 6.Complete author list will be included at presentation, 7.AveXis, Inc., Bannockburn, IL, USA, 8.Center for Gene Therapy Nationwide Childrens Hospital, Columbus, OH, USA)
Roxana Dreghici1, Kathryn R. Wagner2, Brenda L. Wong3,4, Barry J. Byrne5, Cuixia Tian4, Leslie K. Jacobsen6, Giridhar S. Tirucherai6, Michael Rabbia7, Heidemarie Kletzl1, Karl Yen1, Gautam Sajeev8, James Signorovitch8,9, Susan J. Ward9, Michelle Krishnan1 (1.F. Hoffmann-La Roche, Basel, Switzerland, 2.The Johns Hopkins School of Medicine, Baltimore, MD, USA, 3.UMass Memorial Children’s Medical Center, Worcester, MA, US, 4.Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA, 5.University of Florida, Gainesville, FL, USA, 6.Bristol-Myers Squibb, Princeton, NJ, USA, 7.Genentech Inc, South San Francisco, CA, USA, 8.Analysis Group, Inc., Boston, MA, USA, 9.Collaborative Trajectory Analysis Project(cTAP), Cambridge, MA, USA)
Takahiro Yonekawa1,2, Sara El-Hattab1, Kevin P. Campbell1 (1.Howard Hughes Medical Institute, Department of Molecular Physiology and Biophysics, Department of Neurology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, IA, USA, 2.Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan)